RONCA, ROBERTO
RONCA, ROBERTO
Dipartimento di Medicina Molecolare e Traslazionale
4-(3-Phenyl-4-(3,4,5-trimethoxybenzoyl)-1H-pyrrol-1-yl)benzenesulfonamide, a Novel Carbonic Anhydrase and Wnt/β-Catenin Signaling Pathway Dual-Targeting Inhibitor with Potent Activity against Multidrug Resistant Cancer Cells
2023-01-01 Masci, D.; Puxeddu, M.; Di Magno, L.; D'Ambrosio, M.; Parisi, A.; Nalli, M.; Bai, R.; Coluccia, A.; Sciò, P.; Orlando, V.; D'Angelo, S.; Biagioni, S.; Urbani, A.; Hamel, E.; Nocentini, A.; Filiberti, S.; Turati, M.; Ronca, R.; Kopecka, J.; Riganti, C.; Fionda, C.; Bordone, R.; Della Rocca, G.; Canettieri, G.; Supuran, C. T.; Silvestri, R.; La Regina, G.
A facile synthesis of diaryl pyrroles led to the discovery of potent colchicine site antimitotic agents
2021-01-01 Romagnoli, R.; Oliva, P.; Salvador, M. K.; Manfredini, S.; Padroni, C.; Brancale, A.; Ferla, S.; Hamel, E.; Ronca, R.; Maccarinelli, F.; Rruga, F.; Mariotto, E.; Viola, G.; Bortolozzi, R.
A hybrid spatiotemporal model of PCa dynamics and insights into optimal therapeutic strategies
2023-01-01 Burbanks, A.; Cerasuolo, M.; Ronca, R.; Turner, L.
A long pentraxin-3-derived pentapeptide for the therapy of FGF8b-driven steroid hormone-regulated cancers
2015-01-01 Giacomini, Arianna; Matarazzo, Sara; Pagano, Katiuscia; Ragona, Laura; Rezzola, Sara; Corsini, Michela; Salle, Emanuela Di; Presta, Marco; Ronca, Roberto
An embryonic stem cell perspective for FGFR1 signaling in cardiovascular development
2004-01-01 Ronca, Roberto; Dell'Era, Patrizia; Nicoli, S.; Presta, AND M.
An orthotopic model of uveal melanoma in zebrafish embryo: A novel platform for drug evaluation
2021-01-01 Tobia, C.; Coltrini, D.; Ronca, R.; Loda, A.; Guerra, J.; Scalvini, E.; Semeraro, F.; Rezzola, S.
ANTI-ANGIOGENIC ACTIVITY OF A NEUTRALIZING HUMAN SINGLE-CHAIN ANTIBODY FRAGMENT AGAINST FIBROBLAST GROWTH FACTOR RECEPTOR 1
2010-01-01 Ronca, Roberto; Patrizia, Benzoni; Leali, Daria; Chiara, Urbinati; Belleri, Mirella; Corsini, Michela; Alessi, Patrizia; Coltrini, Daniela; Calza, Stefano; Presta, Marco; Dell'Era, Patrizia
Antiangiogenic activity of semisynthetic biotechnological heparins: low-molecular-weight-sulfated Escherichia coli K5 polysaccharide derivatives as fibroblast growth factor antagonists.
2005-01-01 Presta, Marco; Oreste, P; Zoppetti, G; Belleri, Mirella; Tanghetti, Elena; Leali, D; Urbinati, Chiara Eva; Bugatti, Antonella; Ronca, Roberto; Nicoli, S; Moroni, Emanuela; Stabile, H; Camozzi, Maura; Hernandez, Ga; Mitola, Stefania Maria Filomena; Dell'Era, Patrizia; Rusnati, Marco; Ribatti, D.
Antiangiogenic effects of N6-isopentenyladenosine, an endogenous isoprenoid end product, mediated by AMPK activation.
2014-01-01 Pisanti, S.; Picardi, P.; Ciaglia, E.; Margarucci, L.; Ronca, Roberto; Giacomini, Arianna; Malfitano, A. M.; Casapullo, A.; Laezza, C.; Gazzerro, P.; Bifulco, M.
Antiproliferative effects of sulphonamide carbonic anhydrase inhibitors C18, SLC-0111 and acetazolamide on bladder, glioblastoma and pancreatic cancer cell lines
2022-01-01 Mussi, S.; Rezzola, S.; Chiodelli, P.; Nocentini, A.; Supuran, C. T.; Ronca, R.
Benzenesulfonamides with different rigidity-conferring linkers as carbonic anhydrase inhibitors: an insight into the antiproliferative effect on glioblastoma, pancreatic, and breast cancer cells
2022-01-01 Liguori, F.; Carradori, S.; Ronca, R.; Rezzola, S.; Filiberti, S.; Carta, F.; Turati, M.; Supuran, C. T.
Beta-Galactosylceramidase deficiency: neurovascular implications
2011-01-01 Belleri, Mirella; Coltrini, Daniela; Nico, B.; Ribatti, D.; Ronca, Roberto; Alessi, Patrizia; Zizioli, Daniela; Poliani, Pietro Luigi; Marchesini, Sergio; Bongarzone, E.; Presta, Marco
Blocking the FGF/FGFR system as a "two-compartment" antiangiogenic/antitumor approach in cancer therapy.
2016-01-01 Giacomini, Arianna; Chiodelli, Paola; Matarazzo, Sara; Rusnati, Marco; Presta, Marco; Ronca, Roberto
Cannabidiol alters mitochondrial bioenergetics via VDAC1 and triggers cell death in hormone-refractory prostate cancer
2023-01-01 Mahmoud, A. M.; Kostrzewa, M.; Marolda, V.; Cerasuolo, M.; Maccarinelli, F.; Coltrini, D.; Rezzola, S.; Giacomini, A.; Mollica, M. P.; Motta, A.; Paris, D.; Zorzano, A.; Marzo, V. D.; Ronca, R.; Ligresti, A.
Caveolin-1 enhances metastasis formation in a human model of embryonal rhabdomyosarcoma through Erk signaling cooperation
2019-01-01 Codenotti, Silvia; Faggi, Fiorella; Ronca, Roberto; Chiodelli, Paola; Grillo, Elisabetta; Guescini, Michele; Megiorni, Francesca; Marampon, Francesco; Fanzani, Alessandro
Caveolin-1 overexpression accelerates tumor growth and metastasis of embryonal rhabdomyosarcoma
2017-01-01 Pinardi, Luca; Faggi, Fiorella; Ronca, Roberto; Codenotti, Silvia; Fanzani, Alessandro
Caveolin-1 overexpression in the human embryonal rhabdomyosarcoma RD cells increases tumor growth and metastasis in vivo through a phospho-ERK-dependent signaling pathway
2016-01-01 Faggi, Fiorella; Ronca, Roberto; Codenotti, Silvia; Monti, Eugenio; Fanzani, Alessandro
Cavin-1 and Caveolin-1 are both required to support cell proliferation, migration and anchorage-independent cell growth in rhabdomyosarcoma
2015-01-01 Faggi, Fiorella; Chiarelli, Nicola; Colombi, Marina; Mitola, Stefania Maria Filomena; Ronca, Roberto; Madaro, Luca; Bouche’, Marina; Poliani, Pietro Luigi; Vezzoli, Marika; Longhena, Francesca; Monti, Eugenio; Salani, Barbara; Maggi, Davide; Keller, Charles; Fanzani, Alessandro
Cavin-1 and Caveolin-1 are both required to support cell proliferation, migration and anchorage-independent cell growth in rhabdomyosarcoma.
2015-01-01 Faggi, Fiorella; Chiarelli, Nicola; Colombi, Marina; Mitola, Stefania Maria Filomena; Ronca, Roberto; Madaro, Luca; Bouche’, Marina; Poliani, Pietro Luigi; Vezzoli, Marika; Longhena, Francesca; Monti, Eugenio; Salani, Barbara; Maggi, Davide; Keller, Charles; Fanzani, Alessandro
Chemical modification of NSC12 leads to a specific FGF-trap with antitumor activity in multiple myeloma
2021-01-01 Castelli, R.; Taranto, S.; Furiassi, L.; Bozza, N.; Marseglia, G.; Ferlenghi, F.; Rivara, S.; Retini, M.; Bedini, A.; Spadoni, G.; Matarazzo, S.; Ronca, R.; Presta, M.; Mor, M.; Giacomini, A.
| Titolo | Data di pubblicazione | Autore(i) | File |
|---|---|---|---|
| 4-(3-Phenyl-4-(3,4,5-trimethoxybenzoyl)-1H-pyrrol-1-yl)benzenesulfonamide, a Novel Carbonic Anhydrase and Wnt/β-Catenin Signaling Pathway Dual-Targeting Inhibitor with Potent Activity against Multidrug Resistant Cancer Cells | 1-gen-2023 | Masci, D.; Puxeddu, M.; Di Magno, L.; D'Ambrosio, M.; Parisi, A.; Nalli, M.; Bai, R.; Coluccia, A.; Sciò, P.; Orlando, V.; D'Angelo, S.; Biagioni, S.; Urbani, A.; Hamel, E.; Nocentini, A.; Filiberti, S.; Turati, M.; Ronca, R.; Kopecka, J.; Riganti, C.; Fionda, C.; Bordone, R.; Della Rocca, G.; Canettieri, G.; Supuran, C. T.; Silvestri, R.; La Regina, G. | |
| A facile synthesis of diaryl pyrroles led to the discovery of potent colchicine site antimitotic agents | 1-gen-2021 | Romagnoli, R.; Oliva, P.; Salvador, M. K.; Manfredini, S.; Padroni, C.; Brancale, A.; Ferla, S.; Hamel, E.; Ronca, R.; Maccarinelli, F.; Rruga, F.; Mariotto, E.; Viola, G.; Bortolozzi, R. | |
| A hybrid spatiotemporal model of PCa dynamics and insights into optimal therapeutic strategies | 1-gen-2023 | Burbanks, A.; Cerasuolo, M.; Ronca, R.; Turner, L. | |
| A long pentraxin-3-derived pentapeptide for the therapy of FGF8b-driven steroid hormone-regulated cancers | 1-gen-2015 | Giacomini, Arianna; Matarazzo, Sara; Pagano, Katiuscia; Ragona, Laura; Rezzola, Sara; Corsini, Michela; Salle, Emanuela Di; Presta, Marco; Ronca, Roberto | |
| An embryonic stem cell perspective for FGFR1 signaling in cardiovascular development | 1-gen-2004 | Ronca, Roberto; Dell'Era, Patrizia; Nicoli, S.; Presta, AND M. | |
| An orthotopic model of uveal melanoma in zebrafish embryo: A novel platform for drug evaluation | 1-gen-2021 | Tobia, C.; Coltrini, D.; Ronca, R.; Loda, A.; Guerra, J.; Scalvini, E.; Semeraro, F.; Rezzola, S. | |
| ANTI-ANGIOGENIC ACTIVITY OF A NEUTRALIZING HUMAN SINGLE-CHAIN ANTIBODY FRAGMENT AGAINST FIBROBLAST GROWTH FACTOR RECEPTOR 1 | 1-gen-2010 | Ronca, Roberto; Patrizia, Benzoni; Leali, Daria; Chiara, Urbinati; Belleri, Mirella; Corsini, Michela; Alessi, Patrizia; Coltrini, Daniela; Calza, Stefano; Presta, Marco; Dell'Era, Patrizia | |
| Antiangiogenic activity of semisynthetic biotechnological heparins: low-molecular-weight-sulfated Escherichia coli K5 polysaccharide derivatives as fibroblast growth factor antagonists. | 1-gen-2005 | Presta, Marco; Oreste, P; Zoppetti, G; Belleri, Mirella; Tanghetti, Elena; Leali, D; Urbinati, Chiara Eva; Bugatti, Antonella; Ronca, Roberto; Nicoli, S; Moroni, Emanuela; Stabile, H; Camozzi, Maura; Hernandez, Ga; Mitola, Stefania Maria Filomena; Dell'Era, Patrizia; Rusnati, Marco; Ribatti, D. | |
| Antiangiogenic effects of N6-isopentenyladenosine, an endogenous isoprenoid end product, mediated by AMPK activation. | 1-gen-2014 | Pisanti, S.; Picardi, P.; Ciaglia, E.; Margarucci, L.; Ronca, Roberto; Giacomini, Arianna; Malfitano, A. M.; Casapullo, A.; Laezza, C.; Gazzerro, P.; Bifulco, M. | |
| Antiproliferative effects of sulphonamide carbonic anhydrase inhibitors C18, SLC-0111 and acetazolamide on bladder, glioblastoma and pancreatic cancer cell lines | 1-gen-2022 | Mussi, S.; Rezzola, S.; Chiodelli, P.; Nocentini, A.; Supuran, C. T.; Ronca, R. | |
| Benzenesulfonamides with different rigidity-conferring linkers as carbonic anhydrase inhibitors: an insight into the antiproliferative effect on glioblastoma, pancreatic, and breast cancer cells | 1-gen-2022 | Liguori, F.; Carradori, S.; Ronca, R.; Rezzola, S.; Filiberti, S.; Carta, F.; Turati, M.; Supuran, C. T. | |
| Beta-Galactosylceramidase deficiency: neurovascular implications | 1-gen-2011 | Belleri, Mirella; Coltrini, Daniela; Nico, B.; Ribatti, D.; Ronca, Roberto; Alessi, Patrizia; Zizioli, Daniela; Poliani, Pietro Luigi; Marchesini, Sergio; Bongarzone, E.; Presta, Marco | |
| Blocking the FGF/FGFR system as a "two-compartment" antiangiogenic/antitumor approach in cancer therapy. | 1-gen-2016 | Giacomini, Arianna; Chiodelli, Paola; Matarazzo, Sara; Rusnati, Marco; Presta, Marco; Ronca, Roberto | |
| Cannabidiol alters mitochondrial bioenergetics via VDAC1 and triggers cell death in hormone-refractory prostate cancer | 1-gen-2023 | Mahmoud, A. M.; Kostrzewa, M.; Marolda, V.; Cerasuolo, M.; Maccarinelli, F.; Coltrini, D.; Rezzola, S.; Giacomini, A.; Mollica, M. P.; Motta, A.; Paris, D.; Zorzano, A.; Marzo, V. D.; Ronca, R.; Ligresti, A. | |
| Caveolin-1 enhances metastasis formation in a human model of embryonal rhabdomyosarcoma through Erk signaling cooperation | 1-gen-2019 | Codenotti, Silvia; Faggi, Fiorella; Ronca, Roberto; Chiodelli, Paola; Grillo, Elisabetta; Guescini, Michele; Megiorni, Francesca; Marampon, Francesco; Fanzani, Alessandro | |
| Caveolin-1 overexpression accelerates tumor growth and metastasis of embryonal rhabdomyosarcoma | 1-gen-2017 | Pinardi, Luca; Faggi, Fiorella; Ronca, Roberto; Codenotti, Silvia; Fanzani, Alessandro | |
| Caveolin-1 overexpression in the human embryonal rhabdomyosarcoma RD cells increases tumor growth and metastasis in vivo through a phospho-ERK-dependent signaling pathway | 1-gen-2016 | Faggi, Fiorella; Ronca, Roberto; Codenotti, Silvia; Monti, Eugenio; Fanzani, Alessandro | |
| Cavin-1 and Caveolin-1 are both required to support cell proliferation, migration and anchorage-independent cell growth in rhabdomyosarcoma | 1-gen-2015 | Faggi, Fiorella; Chiarelli, Nicola; Colombi, Marina; Mitola, Stefania Maria Filomena; Ronca, Roberto; Madaro, Luca; Bouche’, Marina; Poliani, Pietro Luigi; Vezzoli, Marika; Longhena, Francesca; Monti, Eugenio; Salani, Barbara; Maggi, Davide; Keller, Charles; Fanzani, Alessandro | |
| Cavin-1 and Caveolin-1 are both required to support cell proliferation, migration and anchorage-independent cell growth in rhabdomyosarcoma. | 1-gen-2015 | Faggi, Fiorella; Chiarelli, Nicola; Colombi, Marina; Mitola, Stefania Maria Filomena; Ronca, Roberto; Madaro, Luca; Bouche’, Marina; Poliani, Pietro Luigi; Vezzoli, Marika; Longhena, Francesca; Monti, Eugenio; Salani, Barbara; Maggi, Davide; Keller, Charles; Fanzani, Alessandro | |
| Chemical modification of NSC12 leads to a specific FGF-trap with antitumor activity in multiple myeloma | 1-gen-2021 | Castelli, R.; Taranto, S.; Furiassi, L.; Bozza, N.; Marseglia, G.; Ferlenghi, F.; Rivara, S.; Retini, M.; Bedini, A.; Spadoni, G.; Matarazzo, S.; Ronca, R.; Presta, M.; Mor, M.; Giacomini, A. |